Research Topics
| Jan J OchnioSummaryAffiliation: University of British Columbia Country: Canada Publications
| Collaborators
|
Detail Information
Publications
Participant-collected, mail-delivered oral fluid specimens can replace traditional serosurveys: a demonstration-of-feasibility survey of hepatitis A virus-specific antibodies in adultsJan J Ochnio
University of British Columbia, Department of Pediatrics, Vaccine Evaluation Centre, Vancouver
Can J Public Health 98:37-40. 2007..Use of participant self-collected oral fluid as a diagnostic specimen and mail for specimen delivery has the potential of generating reliable, population-representative data at limited cost...
Seroprevalence of hepatitis A infection in a low endemicity country: a systematic reviewBa Pham
Biomedical Data Sciences, GlaxoSmithKline, Ontario, Canada
BMC Infect Dis 5:56. 2005..This systematic review aimed to 1) estimate age-specific prevalence of HAV antibody in Canada and 2) evaluate infection-associated risk factors...
Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programsJ J Ochnio
Vaccine Evaluation Center, British Columbia s Children s Hospital and University of British Columbia
CMAJ 165:293-7. 2001....
A nationwide survey of past hepatitis A infections among Canadian adultsDavid W Scheifele
University of British Columbia, Vancouver, BC, Canada
Vaccine 28:5174-8. 2010..A nationwide pediatric serosurvey in 2003 confirmed that HAV infection is uncommon in children. Additional seroepidemiological data for adults would help to guide domestic use of HAV vaccines...
Cellular immunity as a potential cause of local reactions to booster vaccination with diphtheria and tetanus toxoids and acellular pertussis antigensDavid W Scheifele
Vaccine Evaluation Center, BC Children s Hospital, University of British Columbia, Vancouver, British Columbia, Canada
Pediatr Infect Dis J 28:985-9. 2009..Cell-mediated immunity (CMI) develops after primary DTaP vaccination and might contribute to local reactions to booster doses, a possibility explored in this study...
Immunologic considerations for the timing of the booster dose of 7-valent pneumococcal conjugate vaccine in young childrenDavid W Scheifele
Vaccine Evaluation Center, BC Children s Hospital and the University of British Columbia, Vancouver, BC, Canada
Pediatr Infect Dis J 26:387-92. 2007....
